BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38072937)

  • 21. Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic.
    Elfström M; Gray PG; Dillner J
    Elife; 2023 Dec; 12():. PubMed ID: 38085566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
    Tranberg M; Jensen JS; Bech BH; Andersen B
    BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
    Boggan JC; Walmer DK; Henderson G; Chakhtoura N; McCarthy SH; Beauvais HJ; Smith JS
    Sex Transm Dis; 2015 Nov; 42(11):655-9. PubMed ID: 26462192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
    Balasubramanian A; Kulasingam SL; Baer A; Hughes JP; Myers ER; Mao C; Kiviat NB; Koutsky LA
    J Low Genit Tract Dis; 2010 Jul; 14(3):185-95. PubMed ID: 20592553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical Human Papillomavirus Testing With Two Home Self-Collection Methods Compared With a Standard Clinically Collected Sampling Method.
    McLarty JW; Williams DL; Loyd S; Hagensee ME
    Sex Transm Dis; 2019 Oct; 46(10):670-675. PubMed ID: 31517806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Study of the Impact and Restitutive Efforts of Cervical Cancer Screening during the COVID-19 Pandemic in a Regional Cancer Centre in Eastern India.
    Bose S; Basu P; Mandal R; Chakrabarti J; Vernekar M; Banerjee D; Chatterjee P; Ray C
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3495-3500. PubMed ID: 37898855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CoCoss-Trial: Concurrent Comparison of Self-Sampling Devices for HPV-Detection.
    Ertik FC; Kampers J; Hülse F; Stolte C; Böhmer G; Hillemanns P; Jentschke M
    Int J Environ Res Public Health; 2021 Oct; 18(19):. PubMed ID: 34639688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics.
    Ducancelle A; Reiser J; Pivert A; Le Guillou-Guillemette H; Le Duc-Banaszuk AS; Lunel-Fabiani F
    J Infect; 2015 Sep; 71(3):377-84. PubMed ID: 25964233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
    Devotta K; Vahabi M; Prakash V; Lofters A
    BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
    Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 35. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
    Ejegod DM; Pedersen H; Pedersen BT; Serizawa R; Bonde J
    Prev Med; 2022 Jul; 160():107096. PubMed ID: 35594924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.
    Spees LP; Des Marais AC; Wheeler SB; Hudgens MG; Doughty S; Brewer NT; Smith JS
    Trials; 2019 Dec; 20(1):788. PubMed ID: 31881928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
    Polman NJ; Ebisch RMF; Heideman DAM; Melchers WJG; Bekkers RLM; Molijn AC; Meijer CJLM; Quint WGV; Snijders PJF; Massuger LFAG; van Kemenade FJ; Berkhof J
    Lancet Oncol; 2019 Feb; 20(2):229-238. PubMed ID: 30658933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
    Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.